Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-center Study Evaluating the Safety of Long-term Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.

NCT00741819 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT00741819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00741819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-center Study Evaluating the Safety of Long-term Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
Lead sponsor
United Therapeutics
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2008
Completion date
December 31, 2010
Enrollment
73 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension